Snark Meter Posted: October 10, 2006 In the course of writing Pharma Marketing Blog, I have come across many comments from people. Most -- I am happy to say -- are positive. One comment, however, referred to my post on the Rozerem DTC ad campaign as "snarky." I wasn't sure what the word meant, but it didn't sound good. So, I "Googled" it. There are actually several variations of definitions that are more or less positive. I find that different bloggers fall under one or another of the variants. I am happy to say that one fits my mission statement. To find out what the word means and give your opinion as to which definition applies to Pharma Marketing Blog in a polls, see today's post to Pharma Marketing Blog. For more posts in related topic areas, see: Sleep Aid Drugs If you wish to receive notice by email whenever a post is made to Pharma Marketing Blog, please subscribe. Enter your Email Address | Return to Pharma Marketing Blog Topics |

Special Supplement Physician Education Key Opinion Leaders, Medical Science Liaisons, & CME More than ever, it is important to educate physicians about new drugs and to keep this education separate from the marketing function of the company yet aligned with commercial goals. This Special Supplement to Pharma Markeing News is critical reading for pharmaceutical companies and physician education service providers wishing to understand the new roles of key opinion leader physicians (KOLs) and medical science liaisons (MSLs) in the physician education process. TABLE OF CONTENTS Order and pay for this Special Supplement now using your credit card. ONLY $29.95 PDF file delivered to you by email (usually within minutes of placing your order). If you wish to pay by check or credit card off-line, please use: Printable Order Form